Consensus DR Horton

Equities

DHI

US23331A1097

Market Closed - Nyse 04:00:02 2024-07-12 pm EDT 5-day change 1st Jan Change
153.7 USD +2.68% Intraday chart for DR Horton +13.41% +1.16%

Evolution of the average Target Price on DR Horton

Price target over the last 5 years

History of analyst recommendation changes

a1b744410e3e7c22a1b.cgaaZZfJagV1gPPahJ6R6Hn4LbnHhZl7gFPrzeP5-P8.GW7ODcOEAWhNzYaA5uzdmh6AbMGN5tcN3xukhJfLrYsabatW__4AWiD6ug~dedac1e3e95cb97ac34e0f6cde28baea
Barclays Adjusts Price Target on D.R. Horton to $168 From $176 MT
Goldman Sachs Adjusts Price Target on D.R. Horton to $168 From $175 MT
Citigroup Downgrades D.R. Horton to Neutral From Buy, Adjusts Price Target to $156 From $181 MT
ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... Our Logo
Citigroup Adjusts Price Target on D.R. Horton to $181 From $191 MT
Keefe Bruyette & Woods Adjusts Price Target on D.R. Horton to $178 From $172 MT
D R Horton Insider Sold Shares Worth $301,400, According to a Recent SEC Filing MT
Argus Adjusts Price Target on D.R. Horton to $165 From $160 MT
ANALYST RECOMMENDATIONS : Apple, Alphabet, AT&T, Equifax, Darktrace... Our Logo
Raymond James Adjusts Price Target on D.R. Horton to $170 From $160 MT
JPMorgan Lowers D.R. Horton Price Target to $163 From $164 MT
UBS Raises D.R. Horton Price Target to $200 from $192, Buy Rating Kept MT
Jefferies Adjusts D.R. Horton's Price Target to $153 From $141 MT
BTIG Trims D.R. Horton Price Target to $168 from $169 MT
Goldman Sachs Adjusts D.R. Horton Price Target to $175 From $176 MT
Evercore ISI Adjusts D.R. Horton Price Target to $191 From $193 MT
Barclays Adjusts D.R. Horton Price Target to $176 From $186 MT
RBC Trims Price Target on D.R. Horton to $141 From $142, Notes 'Renewed Rate Pressure/Uncertainty,' Keeps Underperform Rating MT
BTIG Adjusts D.R. Horton's Price Target to $169 From $174, Maintains Buy Rating MT
Zelman & Associates Downgrades D.R. Horton to Neutral From Outperform MT
Citigroup Raises Price Target on D.R. Horton to $191 From $166, Maintains Buy Rating MT
Barclays Raises Price Target on D.R. Horton to $186 From $166, Maintains Overweight Rating MT
Lennar: in the red, a broker downgrades its opinion CF
Wedbush Downgrades D.R. Horton to Underperform From Neutral, PT is $130; Says Could See Normal Seasonal Stock Price Decline Into Summer MT
Raymond James Adjusts D.R. Horton's Price Target to $160 From $140, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
153.7 USD
Average target price
167.6 USD
Spread / Average Target
+9.00%
High Price Target
200 USD
Spread / Highest target
+30.09%
Low Price Target
130 USD
Spread / Lowest Target
-15.44%

Consensus detail

Consensus revision (last 18 months)

Analysts covering DR Horton

Citigroup
Keefe, Bruyette & Woods
Argus
Raymond James
JPMorgan Chase
UBS
Jefferies & Co.
BTIG
Goldman Sachs
Evercore ISI
Barclays
RBC Capital Markets
Zelman & Associates
Wedbush
JMP Securities
Seaport Global Securities
BofA Securities
Deutsche Bank Securities
Morningstar
Credit Suisse
Wolfe Research
KeyBanc Capital Markets
Wells Fargo Securities
Janney Capital
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings